Rx&D Welcomes its Newest Member: EndoCeutics Inc.

OTTAWA, April 6 /CNW/ - Canada's Research-Based Pharmaceutical Companies (Rx&D) President Russell Williams, is pleased to welcome a new member to the association representing the innovative pharmaceutical industry in Canada.

EndoCeutics Inc., which is based in Quebec City, has joined Rx&D as a biopharmaceutical member.

EndoCeutics is a private bio-pharma company operating in the field of women's health and is focused on developing non-estrogen-based therapies for problems of menopause, as well as hormone therapy for prevention and treatment of Breast Cancer.

"We've succeeded in creating a world-class health research centre specialized in the mechanisms of menopause and hormone-sensitive cancers," said Dr. Fernand Labrie, President and CEO of EndoCeutics Inc. "Joining Rx&D is another step in building our capacity and capability so we can continue to develop products that save lives and improve the quality of life of patients worldwide while benefiting the economy of Quebec and Canada."

EndoCeutics was established in 2006 as the late-stage development and commercialization vehicle for EndoResearch Inc., a company responsible for major advances in the field of prostate cancer.

"More and more companies of Canada's life sciences sector are recognizing the value and benefits of becoming members of Rx&D. We are pleased to welcome EndoCeutics as a member our association," said Rx&D President Russell Williams.

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents 15,000 men and women working for 50 member companies and invests more than $1 billion in research and development each year to fuel Canada's knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.

SOURCE CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX

For further information:

Mike Murphy, Communications
Telephone: 613.236.0455
E-mail: mmurphy@canadapharma.org

Profil de l'entreprise

CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.